This NeuroSense Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday
Author: Avi Kapoor | May 12, 2025 09:20am
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
D. Boral Capital analyst Jason Kolbert initiated coverage on NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) with a Buy rating and announced a price target of $14. NeuroSense Therapeutics shares closed at $1.0438 on Friday. See how other analysts view this stock.
Maxim Group analyst Jason McCarthy initiated coverage on ProMIS Neurosciences, Inc. (NASDAQ:PMN) with a Buy rating and announced a price target of $3. ProMIS Neurosciences shares closed at $0.5020 on Friday. See how other analysts view this stock.
Maxim Group initiated coverage on Primis Financial Corp. (NASDAQ:FRST) with a Buy rating and announced a price target of $1. Primis Finl shares closed at $8.96 on Friday. See how other analysts view this stock.
Considering buying NRSN stock? Here’s what analysts think:
